XML 25 R11.htm IDEA: XBRL DOCUMENT
v3.25.3

Loans Receivable | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2025 | Dec. 31, 2024
Receivables [Abstract] |  |
Loans Receivable | Note 5 - Loans Receivable The Company’s loans receivable, which is classified as held for sale as of June 30, 2025, is comprised of a commercial real estate loan and is stated at the lower of cost or fair value. As of June 30, 2025, and December 31, 2024, the loan is performing, with no allowance for credit losses recorded. The following table summarizes the commercial real estate loans receivable balances: Schedule of Commercial Real Estate Loans Receivable
|  | June 30, 2025 |  |  | December 31, 2024 |
Commercial real estate loans receivable, gross |  | $ | 385,642 |  |  | $ | 392,186 |
Allowance for credit losses |  |  | - |  |  |  | - |
Transferred to held for sale |  |  | (385,642 | ) |  |  | - |
Commercial real estate loans receivable, net |  |  | - |  |  |  | 392,186 |
Current portion |  |  | - |  |  |  | (13,332 | )
Non-current portion |  | $ | - |  |  | $ | 378,854 |
The Company’s loan receivable was sold to PCCU in July 2025. The Company reflected this asset as held for sale in the condensed consolidated unaudited balance sheet. See Note 18, Subsequent Events for the sale of the commercial real estate loan to PCCU | Note 5. Loans Receivable Commercial real estate loans receivable, net consist of the following: Schedule of Commercial Real Estate Loans Receivable
|  | December 31, 2024 |  |  | December 31, 2023 |
Commercial real estate loans receivable, gross |  | $ | 392,186 |  |  | $ | 404,577 |
Allowance for credit losses |  |  | - |  |  |  | (10,723 | )
Commercial real estate loans receivable, net |  |  | 392,186 |  |  |  | 393,854 |
Current portion |  |  | (13,332 | ) |  |  | (12,391 | )
Noncurrent portion |  | $ | 378,854 |  |  | $ | 381,463 |
Allowance for Credit Losses The allowance for credit losses is maintained at a level believed to be sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the loan portfolio. The Company’s estimated the allowance for credit losses on the reporting date in accordance with the credit loss policy described in Note 2. The allowance for credit losses consists of the following activity for the year ended December 31, 2024 and 2023: Schedule of Allowance For Loan Losses
Year ended December 31, |  | 2024 |  |  | 2023 |
Allowance for credit losses |  |  |  |  |  |  |  |
Beginning balance |  | $ | 10,723 |  |  | $ | 21,488 |
Cumulative effect from adoption of CECL |  |  | - |  |  |  | 14,980 |
Charge-offs |  |  | - |  |  |  | - |
Recoveries |  |  | - |  |  |  | - |
Benefits |  |  | (10,723 | ) |  |  | (25,745 | )
Ending balance |  | $ | - |  |  | $ | 10,723 |
Loans receivable: |  |  |  |  |  |  |  |
Individually evaluated for impairment |  | $ | 392,186 |  |  | $ | - |
Collectively evaluated for impairment |  |  | - |  |  |  | 404,577 |
|  | $ | 392,186 |  |  | $ | 404,577 |
Allowance for credit losses: |  |  |  |  |  |  |  |
Individually evaluated for impairment |  | $ | - |  |  | $ | - |
Collectively evaluated for impairment |  |  | - |  |  |  | 10,723 |
|  | $ | - |  |  | $ | 10,723 |
As of December 31, 2024 and December 31, 2023, no loans were past due, or classified as non-accrual or considered impaired. Additionally, no loans were modified during the years ended December 31, 2024, or 2023. Credit quality of loans: As part of the on-going monitoring of the credit quality of the Company’s loan portfolio, management tracks credit quality indicators based on the loan payment status on monthly basis. The Company evaluated the credit quality of each indemnified loan by assessing the risk factors and assigning a risk rating based on a variety of factors. The detailed breakdown of risk factors described in Note 6. The carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value within each risk rating is as follows: Schedule of Risk Rating
Risk rating |  | Year ended. December 31, 2024 |  |  | Year ended December 31, 2023 |
6 |  | $ | 392,186 |  |  | $ | - |
4 |  |  | - |  |  |  | 404,577 |
Grand total |  | $ | 392,186 |  |  | $ | 404,577 |

X
- Definition The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/310-10/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2 + Details
Name: | us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration